Cargando…
Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238273/ https://www.ncbi.nlm.nih.gov/pubmed/34160415 http://dx.doi.org/10.1097/MD.0000000000026384 |
_version_ | 1783714869853290496 |
---|---|
author | Besic, Nikola Vidergar-Kralj, Barbara Zaletel, Katja Grasic-Kuhar, Cvetka |
author_facet | Besic, Nikola Vidergar-Kralj, Barbara Zaletel, Katja Grasic-Kuhar, Cvetka |
author_sort | Besic, Nikola |
collection | PubMed |
description | RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyroidism and a tumor measuring 9 cm in diameter of the left thyroid lobe, metastatic neck lymph node and metastases in the lungs, mediastinum, and bones. DIAGNOSIS: Laboratory findings confirmed hyperthyroidism and GD. Fine-needle aspiration biopsy and cytological investigation revealed metastases of HCTC in the skull and in the 8th right rib. A CT examination showed a thyroid tumor, metastatic neck lymph node, metastases in the lungs, mediastinum and in the 8th right rib measuring 20 × 5.6 × 4.5 cm, in the left acetabulum measuring 9 × 9 × 3 cm and parietooccipitally in the skull measuring 5 × 4 × 2 cm. Histology after total thyroidectomy and resection of the 8th right rib confirmed metastatic HCTC. INTERVENTIONS: The region of the left hip had been irradiated with concomitant doxorubicin 20 mg once weekly. When hyperthyroidism was controlled with thiamazole, a total thyroidectomy was performed. Persistent T3 hyperthyroidism, most likely caused by TSH-R-stimulated T3 production in large metastasis in the 8th right rib, was eliminated by rib resection. Thereafter, the patient was treated with 3 radioactive iodine-131 (RAI) therapies (cumulative dose of 515 mCi). Unfortunately, the tumor rapidly progressed after treatment with RAI and progressed 10 months after therapy with sorafenib. OUTCOMES: Despite treatment, the disease rapidly progressed and patient died due to distant metastases. He survived for 28 months from diagnosis. LESSONS: Simultaneous hormone-active HCTC and GD is extremely rare and prognosis is dismal. Concomitant external beam radiotherapy and doxorubicin chemotherapy, followed by RAI therapy, prevented the growth of a large metastasis in the left hip in our patient. However, a large metastasis in the 8th right rib presented an unresolved problem. Treatment with rib resection and RAI did not prevent tumor recurrence. External beam radiotherapy and sorafenib treatment failed to prevent tumor growth. |
format | Online Article Text |
id | pubmed-8238273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-82382732021-07-06 Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report Besic, Nikola Vidergar-Kralj, Barbara Zaletel, Katja Grasic-Kuhar, Cvetka Medicine (Baltimore) 4300 RATIONALE: A hormone-active metastatic Hürthle cell thyroid carcinoma (HCTC) and Graves disease (GD) present a therapeutic challenge and is rarely reported. PATIENT CONCERNS: We present a 64-year-old male patient, who had dyspnea and left hip pain lasting 4 months. He had clinical signs of hyperthyroidism and a tumor measuring 9 cm in diameter of the left thyroid lobe, metastatic neck lymph node and metastases in the lungs, mediastinum, and bones. DIAGNOSIS: Laboratory findings confirmed hyperthyroidism and GD. Fine-needle aspiration biopsy and cytological investigation revealed metastases of HCTC in the skull and in the 8th right rib. A CT examination showed a thyroid tumor, metastatic neck lymph node, metastases in the lungs, mediastinum and in the 8th right rib measuring 20 × 5.6 × 4.5 cm, in the left acetabulum measuring 9 × 9 × 3 cm and parietooccipitally in the skull measuring 5 × 4 × 2 cm. Histology after total thyroidectomy and resection of the 8th right rib confirmed metastatic HCTC. INTERVENTIONS: The region of the left hip had been irradiated with concomitant doxorubicin 20 mg once weekly. When hyperthyroidism was controlled with thiamazole, a total thyroidectomy was performed. Persistent T3 hyperthyroidism, most likely caused by TSH-R-stimulated T3 production in large metastasis in the 8th right rib, was eliminated by rib resection. Thereafter, the patient was treated with 3 radioactive iodine-131 (RAI) therapies (cumulative dose of 515 mCi). Unfortunately, the tumor rapidly progressed after treatment with RAI and progressed 10 months after therapy with sorafenib. OUTCOMES: Despite treatment, the disease rapidly progressed and patient died due to distant metastases. He survived for 28 months from diagnosis. LESSONS: Simultaneous hormone-active HCTC and GD is extremely rare and prognosis is dismal. Concomitant external beam radiotherapy and doxorubicin chemotherapy, followed by RAI therapy, prevented the growth of a large metastasis in the left hip in our patient. However, a large metastasis in the 8th right rib presented an unresolved problem. Treatment with rib resection and RAI did not prevent tumor recurrence. External beam radiotherapy and sorafenib treatment failed to prevent tumor growth. Lippincott Williams & Wilkins 2021-06-25 /pmc/articles/PMC8238273/ /pubmed/34160415 http://dx.doi.org/10.1097/MD.0000000000026384 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 4300 Besic, Nikola Vidergar-Kralj, Barbara Zaletel, Katja Grasic-Kuhar, Cvetka Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title | Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title_full | Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title_fullStr | Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title_full_unstemmed | Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title_short | Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report |
title_sort | graves disease and metastatic hormonal-active hürthle cell thyroid cancer: a case report |
topic | 4300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238273/ https://www.ncbi.nlm.nih.gov/pubmed/34160415 http://dx.doi.org/10.1097/MD.0000000000026384 |
work_keys_str_mv | AT besicnikola gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport AT vidergarkraljbarbara gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport AT zaletelkatja gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport AT grasickuharcvetka gravesdiseaseandmetastatichormonalactivehurthlecellthyroidcanceracasereport |